Department of Cardiology, University of Heidelberg, 69120 Heidelberg, Germany.
DZHK (German Center for Cardiovascular Research), Partner Site Heidelberg/Mannheim, University of Heidelberg, 69120 Heidelberg, Germany.
Cells. 2021 Oct 27;10(11):2914. doi: 10.3390/cells10112914.
Two-pore-domain potassium (K-) channels conduct outward K currents that maintain the resting membrane potential and modulate action potential repolarization. Members of the K channel family are widely expressed among different human cell types and organs where they were shown to regulate important physiological processes. Their functional activity is controlled by a broad variety of different stimuli, like pH level, temperature, and mechanical stress but also by the presence of lipids or pharmacological agents. In patients suffering from cardiovascular diseases, alterations in K-channel expression and function have been observed, suggesting functional significance and a potential therapeutic role of these ion channels. For example, upregulation of atrial specific K3.1 (TASK-1) currents in atrial fibrillation (AF) patients was shown to contribute to atrial action potential duration shortening, a key feature of AF-associated atrial electrical remodelling. Therefore, targeting K3.1 (TASK-1) channels might constitute an intriguing strategy for AF treatment. Further, mechanoactive K2.1 (TREK-1) currents have been implicated in the development of cardiac hypertrophy, cardiac fibrosis and heart failure. Cardiovascular expression of other K channels has been described, functional evidence in cardiac tissue however remains sparse. In the present review, expression, function, and regulation of cardiovascular K channels are summarized and compared among different species. Remodelling patterns, observed in disease models are discussed and compared to findings from clinical patients to assess the therapeutic potential of K channels.
双孔钾 (K) 通道传导外向 K 电流,维持静息膜电位,并调节动作电位复极化。K 通道家族的成员在不同的人类细胞类型和器官中广泛表达,它们被证明可以调节重要的生理过程。它们的功能活性受到多种不同刺激的控制,如 pH 值、温度和机械应激,还受到脂质或药物的存在的影响。在患有心血管疾病的患者中,观察到 K 通道表达和功能的改变,表明这些离子通道具有功能意义和潜在的治疗作用。例如,在心房颤动 (AF) 患者中,心房特异性 K3.1(TASK-1)电流的上调被证明有助于缩短心房动作电位持续时间,这是 AF 相关心房电重构的一个关键特征。因此,靶向 K3.1(TASK-1)通道可能是治疗 AF 的一种有趣策略。此外,机械激活的 K2.1(TREK-1)电流与心肌肥厚、心肌纤维化和心力衰竭的发展有关。已经描述了其他 K 通道在心血管系统中的表达,然而,在心脏组织中的功能证据仍然很少。在本综述中,总结了不同物种中心血管 K 通道的表达、功能和调节,并对其进行了比较。讨论了疾病模型中观察到的重塑模式,并将其与临床患者的发现进行比较,以评估 K 通道的治疗潜力。